Drug intelligence / Profile preview

PEG-Mizone

Development stage
Preclinical
Lead developer
First Affiliated Hospital of Ningbo University
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

**PEG-Mizone** is a trial-defined oral bowel-cleansing regimen in which macrogol 4000, also called polyethylene glycol 4000, is dissolved partly in Mizone vitamin drink and partly in water before colonoscopy. In the registered randomized study, the regimen used split dosing with 60 g macrogol 4000 in 0.6 L Mizone plus 0.4 L water the evening before colonoscopy, followed by 120 g macrogol 4000 in 1.2 L Mizone plus 0.8 L water on the procedure day. Macrogol 4000 acts as a nonabsorbed osmotic laxative that retains water in the intestinal lumen to promote bowel evacuation; Mizone was used as a palatability and hydration beverage adjunct rather than as a separately developed pharmaceutical active ingredient. ([ctv.veeva.com](https://ctv.veeva.com/study/mizone-vs-water-for-bowel-preparation))

Other names
PEG + MizonePEG-4000 + MizonePEG-MizonePEG-Mizone preppolyethylene glycol 4000 + Mizone

Beyond the preview

Go deeper on PEG-Mizone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEG-Mizone.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call